T. Vogt et al., OVEREXPRESSION OF LERK-5 EPLG5 MESSENGER-RNA - A NOVEL MARKER FOR INCREASED TUMORIGENICITY AND METASTATIC POTENTIAL IN HUMAN-MALIGNANT MELANOMAS/, Clinical cancer research, 4(3), 1998, pp. 791-797
The Lerks, ligands of eph-related receptor tyrosine kinases, are a rap
idly expanding family of genes thought to play an important role in th
e development and oncogenesis of various tissues, However, very little
experimental evidence supports this hypothesis, Using RNA fingerprint
ing, we detected increased expression of Lerk-5 mRNA in human melanocy
tes as a response to the tumor-promoting drug 12-O-tetradecanoylphorbo
l-13-acetate, which suggests a possible role of the Lerks in melanoma
tumorigenesis and progression, Therefore, we studied Lerk-5 mRNA expre
ssion in various melanoma cell lines and tissues of melanocytic tumors
by semiquantitative reverse transcription-PCR, Modest expression of L
erk-5 mRNA was found in two melanoma cell lines derived from early pri
mary tumors (WM35 and WM1645B); two metastatic cell lines tested showe
d a 3.9-fold increased transcript abundance when compared to the prima
ry cell lines (RPMI-7951 and SK-MeI5), Progeny of a melanoma cell line
with very low Lerk-5 mRNA abundance (WM35) showed a 5-fold increase i
n Lerk-5 mRNA expression when it was selected for higher tumorigenicit
y and multicytokine resistance by passaging in nude mice or repeated h
igh-dose WE irradiation, Consistent with these experimental data, we f
ound high levels of Lerk-5 mRNA expression in advanced primary maligna
nt melanomas and metastases (n = 22) but significantly lower or undete
ctable mRNA expression in benign melanocytic nevi (n = 9; P < 0.001),
We conclude that increased Lerk-5 expression possibly reflects or indu
ces an increased potential of growth, tumorigenicity, and metastatic a
bilities in human melanomas, This makes the yet to be elucidated eph-r
elated receptor tyrosine kinase/Lerk signaling system a potential new
source for molecular markers as well as a target for new therapies.